A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -69.90% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -68.57%. Over the past 30 days, the price of HSDT has leaped by -60.52%. And in the last five days, it has fallen by -40.83%.
Helius Medical Technologies Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $14.44 on 06/07/23, while the lowest value for the same period was recorded at $2.35 on 05/06/24.
52-week price history of HSDT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Helius Medical Technologies Inc’s current trading price is -83.24% away from its 52-week high, while its distance from the 52-week low is 2.98%. The stock’s price range during this period has varied between$2.35 and $14.44. The Helius Medical Technologies Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.28 million for the day, a figure considerably higher than their average daily volume of 0.6 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Helius Medical Technologies Inc (HSDT) has experienced a quarterly decline of -65.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.15M and boasts a workforce of 22 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.20, with a change in price of -5.16. Similarly, Helius Medical Technologies Inc recorded 396,992 in trading volume during the last 100 days, posting a change of -68.07%.
HSDT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for HSDT stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.00.
HSDT Stock Stochastic Average
Helius Medical Technologies Inc’s raw stochastic average for the past 50 days is presently 3.05%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 3.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.33% and 5.25%, respectively.
